X4 Pharmaceuticals (XFOR) Goodwill (2019 - 2025)

X4 Pharmaceuticals' Goodwill history runs 7 years deep, the most recent figure standing at $17.4 million for Q4 2025.

• Quarterly Goodwill changed 0.0% year-over-year to $17.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $17.4 million (changed 0.0% YoY) and the FY2025 annual result came in at $17.4 million, changed 0.0% from the prior year.
• Goodwill was $17.4 million for Q4 2025 at X4 Pharmaceuticals, roughly flat from $17.4 million in the prior quarter.
• Across five years, Goodwill topped out at $27.1 million in Q1 2021 and bottomed at $17.4 million in Q1 2022.
• A 5-year average of $18.8 million and a median of $17.4 million in 2022 frame the typical range for Goodwill.
• Annual changes were most pronounced in 2021 — Goodwill changed 0.0% — and 2022, when it sank 36.0%.
• X4 Pharmaceuticals' Goodwill stood at $17.4 million in 2021, then dropped by 0.28% to $17.4 million in 2022, then changed by 0.0% to $17.4 million in 2023, then changed by 0.0% to $17.4 million in 2024, then changed by 0.0% to $17.4 million in 2025.
• Business Quant data shows XFOR's Goodwill at $17.4 million in Q4 2025, $17.4 million in Q3 2025, and $17.4 million in Q2 2025.